아스피린 불내성 및 내성 천식 환자에서 혈장 Eotaxin군의 측정치 비교 연구
Comparison of Plasma Eotaxin Family Level in Aspirin-Intolerant and Aspirin-Tolerant Asthma Patients
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: Eosinophilic infiltration of airway tissue is a central feature of aspirin-intolerant asthma (AIA). Eotaxins belong to the family of CC chemokines, which coordinate the recruitment of inflammatory cells bearing chemokine (C-C motif) receptor-3 to sites of allergic inflammation. In the present study, the levels of eotaxin-1, -2 and -3 following an oral aspirin provocation test (APT) were measured, and the relationship between the eotaxin level and clinical parameters in patients with asthma was evaluated. Method: APT was performed in patients with asthma. Twenty patients with AIA and 23 patients with aspirin- tolerant asthma (ATA) were included. Plasma eotaxin-1, -2 and -3 levels were measured by ELISA in 43 patients with asthma and in 39 control subjects. Result: The proportion of blood eosinophils was significantly higher in asthmatics than in control subjects. Nasal polyps were more common in AIA patients than in ATA patients (P<.05). In addition, the eotaxin-1 level was higher in AIA patients and ATA patients than in control subjects (P<.01, respectively). The eotaxin-2 level was higher in ATA patients than in either the AIA (P<.05) patients or control subjects (P<.01). Similarly, the eotaxin-3 level was higher in the ATA patients than in control subjects. A trend toward higher plasma levels of eotaxin-1 and eotaxin-3 was noted at baseline and at 4 h after APT administration in the ATA patients Eotaxin-2 was also higher in ATA patients than in AIA patients at baseline and 4 h after the APT. Conclusion: This study indicated that eotaxin-2 is differentially secreted in patients with asthma according to aspirin intolerance and that secretion is not time-dependent in response to the APT in AIA patients and ATA patients. It is suggested that eotaxin-2 may be up-regulated and act differentially in aspirin-tolerant asthma.
참고문헌 (33)
- "advances in pathogenesis", diag(sis), pp.913~21
- "Slepian IK Aspirin sensitive asthma", pp.386~91
- "and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs", diag(sis), pp.617~22
- "Kette F Aspirin-sensitive asthma", pp.240~6
- "Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects", pp.90~6, Sousa AR
- "Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients", pp.355~7
- "and characterization of the human eosinophil eotaxin receptor", pp.2349~54, expression
- "Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity", pp.935~43
- "Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils", pp.2437~48
- "Association of interleukin-5 and eotaxin with acute exacerbation of asthma", pp.283~90
- "a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation", pp.881~7
- "Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia", pp.449~56
- "and chromosomal location of the gene for human eotaxin", ge(mic organization), pp.471~6
- "Assignment of the human CC chemokine MPIF-2", eotaxin-2 to chromosome 7q11, genomics1998;49, pp.(miyama), 339~40
- "Molecular cloning and characterization of a novel human CC chemokine", pp.313~7
- "Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils", pp.667~75
- "Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors", pp.1163~72
- "Cloning of the human eosinophil chemoattractant and functional properties suggest a mechanism for the selective recruitment of eosinophils", pp.604~12, Expression
- "National Institutes of Health Global strategy for asthma management and prevention" (2002)
- "Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease", pp.225~44
- "Standardization of bronchial inhalation challenge procedures", pp.323~7
- "Collection between RAST and skin test for inhalant offending allergens", pp.1~9
- "Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs", pp.~1751 (1993), principles and practice CV Mosby
- "Molecular cloning of human eotaxin and identification of a specific eosinophil eotaxin receptor", pp.7725~30
- "a novel CC chemokine that is selective for the chemokine receptor CCR3 and acts like eotaxin on human eosinophil and basophil leukocytes", pp.2171~2 6
- "Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells", pp.3507~16
- "Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation", pp.4593~601
- "Eotaxin and impaired lung function in asthma" (1952)
- "Increased expression of the chemoattractant cytokines eotaxin and interleukin-16 in induced sputum in asthmatic patients", pp.595~601
- "Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage of asthmatic patients after allergen inhalation", pp.137~46
- "Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge", oh(na s), pp.682~7
- "Elevated plasma eotaxin levels in patients with acute asthma", pp.786~90
- "eotaxin and eotaxin-2 expression and production in patients with aspirin triad", pp.1165~70
